Benign Prostatic Hyperplasia
Conditions
Interventions
HoLEP group:None
RASP group:None
Sponsors
Chinese PLA General Hospital
Eligibility
Sex/Gender
Male
Age
50 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Male patients, age >= 50 years old; 2. Prostate adenoma volume >= 120 ml and = 8 and/or Qmax = 100 ml and/or continuous catheterization); 4. Life expectancy >= 5 years; 5. Provide informed consent.
Exclusion criteria
Exclusion criteria: 1. History of previous prostate surgery or pelvic radiotherapy; 2. Suspected risk of prostate cancer not ruled out (patient opted out of further evaluation); 3. Concurrent active urinary tract infection; 4. Presence of non-operable severe cardiopulmonary comorbidities or extremely high anesthesia risk; 5. Uncorrectable coagulation disorders or ongoing anticoagulant therapy; 6. Acontractile bladder or severe bladder dysfunction.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The American Urological Association Symptom Score for benign prostatic hyperplasia; | — |
Secondary
| Measure | Time frame |
|---|---|
| Qmax;Post-void residual urine volume;Complications;Sexual and ejaculatory function;Urinary Incontinence;Quality of Life;Reoperation and reintervention rates;operative time;operative blood loss volume; | — |
Countries
China
Contacts
Public ContactXin Ma
Chinese PLA General Hospital
Outcome results
None listed